Berlin named to new leadership post at Vanderbilt-Ingram Cancer Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Jordan Berlin was named associate director of Clinical Investigation Strategy and Shared Resources at the Vanderbilt-Ingram Cancer Center.

In his new role, he will chair the Resource Allocation Committee and continue as chair of the Clinical Trials Shared Resource Steering Committee.

Berlin is an Ingram Professor of Cancer Research, and co-leader of the Gastrointestinal Cancer Research Program and director of the phase I Clinical Trials Program at VICC.

In his new role, Berlin will work closely with Vicki Keedy, medical director of the CTSR, Marta Crispens, chair of the Scientific Review Committee, Ingrid Mayer, chair of the Data and Safety Monitoring Committee, and the operational leaders of the CTSR to optimize operations and facilitate clinical trial services for the VICC membership.

Berlin joined the faculty at Vanderbilt in 1999. He specializes in treating GI cancers.

At VICC, Berlin is the principal investigator of Project 2 and co-director of the Administrative Core for the GI Specialized Program of Research Excellence, a prestigious research grant program funded by the National Cancer Institute.

He also is principal investigator of the Vanderbilt Lead Academic Participating Site Grant with the National Clinical Trials Network and of the UM1 to conduct early-phase trials with the Early Therapeutics Clinical Trials Network.

YOU MAY BE INTERESTED IN

For nearly 25 years, business executive Lou Weisbach and urologist Richard J. Boxer have argued that finding the money to finance the cures for devastating diseases is not as difficult as it appears. To start finding the cures, the U.S. Department of the Treasury needs to issue some bonds—$750 billion worth. Next, you hire CEOs—one...

There is general agreement that the United States spends too much on health care, especially on pharmaceuticals.  But what we spend on drugs is not simply a function of price. If eggs double in price, people can simply cut the number of eggs they eat in half.  Simply stated, cost is the product of (price per unit times the number of units purchased). 
What did President Richard M. Nixon and Senator Edward M. Kennedy have in common? They each played a pivotal role in the passage of the National Cancer Act signed by Nixon on Dec. 23, 1971. The NCA established the National Cancer Program authorizing the initial investment in the NCI-designated Cancer Centers Program. 
When I first proposed targeting PCNA (proliferating cell nuclear antigen) as a therapeutic approach, the response I got was: “No one will ever make a drug against PCNA. It’s undruggable.” The protein lacks enzymatic activity, has a disordered region, and binds to over 200 other proteins within the cell. From a traditional drug development perspective, these characteristics made PCNA an impossible target.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login